Ulcerative Colitis Clinical Trials

1628 clinical trials for Ulcerative Colitis across international registries, including 302 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis — RECRUITING
• A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting — RECRUITING · PHASE4
• A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis — RECRUITING · PHASE3
• A3921210 - OPEN-LABEL INDUCTION AND MAINTENANCE STUDY OF ORAL CP-690,550 (TOFACITINIB) IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS — RECRUITING · PHASE3
• A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis — RECRUITING · PHASE3
• A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) — RECRUITING · PHASE4
• VIBRANT-IBD: Brain Effects of Non-Invasive Vagus Nerve Stimulation in IBD Remission — RECRUITING · PHASE1
• PIBD-SETQuality: the Inception Cohort and Safety Registry — RECRUITING
• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) — RECRUITING · PHASE3
• Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission — RECRUITING · NA
• Immune Regulation in Ulcerative Colitis or Crohn s Disease — RECRUITING
• Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis Remission — RECRUITING · NA
• A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis — RECRUITING · PHASE2
• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: — RECRUITING · PHASE2
• LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis — RECRUITING · PHASE2
• BOOM-IBD2 Pivotal Clinical Trial — RECRUITING · NA
• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study — RECRUITING · PHASE3
• Zymfentra (Infliximab-dyyb) REal World Cohort STudy — RECRUITING
• Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD — RECRUITING · PHASE2
• A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease — RECRUITING · PHASE3
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO — RECRUITING · PHASE1
• Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis — RECRUITING
• A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002) — RECRUITING · PHASE2
• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis — RECRUITING · PHASE2
• A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis — RECRUITING · PHASE2
• The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC — RECRUITING · PHASE2
• Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis — RECRUITING
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC) — RECRUITING · PHASE2
• DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis — RECRUITING
• A Specific Probiotic in thE MOdulation of Gut Microbiota of patieNts With Mild-to-modErate Ulcerative Colitis — RECRUITING · NA
• A Study to Evaluate the Long-term Safety and Efficacy of Long-acting Antibodies as Single Agents and in Combinations in Participants with Inflammatory Bowel Disease — RECRUITING · PHASE2
• Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis — RECRUITING · PHASE1
• Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease — RECRUITING · NA
• Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy（PRECAL） — RECRUITING
• Treatment of UC With Novel Therapeutics — RECRUITING · PHASE2
• Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis — RECRUITING · NA
• Evaluation of the Accuracy of Immunostaining of Claudin 2 to Detect Active or Inactive Inflammation in Endoscopic Biopsies of IBD — RECRUITING
• Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD — RECRUITING
• A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis — RECRUITING · PHASE3
• A randomised, double-blind, double-dummy, multicentre, phase III, non inferiority trial of an oral mesalazine formulation in patients with active mild to moderate ulcerative colitis for the induction of remission. — RECRUITING · PHASE3
• Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (UC) — RECRUITING · NA
• A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis — RECRUITING · PHASE1
• Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD) — RECRUITING
• A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis — RECRUITING · PHASE2
• Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management — RECRUITING · NA
• NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study — RECRUITING
• Stopping PPI Therapy in Inactive IBD — RECRUITING · PHASE4
• IBD Biomarker Discovery and Validation Platform — RECRUITING
• Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA) — RECRUITING · PHASE2
• Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation — RECRUITING · PHASE2

Refine this search